{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T13:16:40Z","timestamp":1782739000645,"version":"3.54.5"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,6,27]],"date-time":"2023-06-27T00:00:00Z","timestamp":1687824000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,6,27]],"date-time":"2023-06-27T00:00:00Z","timestamp":1687824000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Science and Technology Plan of Jiangxi Provincial Health Commission","award":["202210139"],"award-info":[{"award-number":["202210139"]}]},{"name":"Science and Technology Plan of Jiangxi Provincial Health Commission","award":["202210139"],"award-info":[{"award-number":["202210139"]}]},{"name":"Science and Technology Plan of Jiangxi Provincial Health Commission","award":["202210139"],"award-info":[{"award-number":["202210139"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Nephrol"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Vitamin D supplementation is associated with a lower incidence of diabetic nephropathy (DN); however, whether this association is causative is uncertain.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We used two-sample Mendelian randomization to examine the causal influence of vitamin D on diabetic nephropathy in 7,751 individuals with type I diabetes-related nephropathy (T1DN) and 9,933 individuals with type II diabetes-related nephropathy (T2DN). Meanwhile, we repeated some previous studies on the influence of KIM-1 (kidney injury molecule 1) and body mass index (BMI) on DN. Additionally, to test the validity of the instruments variable for vitamin D, we conducted two negative controls Mendelian randomization (MR) on breast and prostate cancer, and a positive control MR on multiple sclerosis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Results of the MR analysis showed that there was no causal association between 25(OH)D with the early\/later stage of T1DN (early: OR\u2009=\u20090.903, 95%CI: 0.229 to 3.555; later: OR\u2009=\u20091.213, 95%CI: 0.367 to 4.010) and T2DN (early: OR\u2009=\u20090.588, 95%CI: 0.182 to 1.904; later: OR\u2009=\u20090.904, 95%CI: 0.376 to 2.173), nor with the kidney function of patients with diabetes mellitus: eGFRcyea (creatinine-based estimated GFR) (Beta\u2009=\u20090.007, 95%CI: -0.355 to 0.369)) or UACR (urinary albumin creatinine ratio) (Beta\u2009=\u20090.186, 95%CI: -0.961 to 1.333)).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>We found no evidence that Vitamin D was causally associated with DN or kidney function in diabetic patients.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12882-023-03186-2","type":"journal-article","created":{"date-parts":[[2023,6,27]],"date-time":"2023-06-27T15:01:17Z","timestamp":1687878077000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["A Mendelian randomization study on causal effects of 25(OH) vitamin D levels on diabetic nephropathy"],"prefix":"10.1186","volume":"24","author":[{"given":"Mingjie","family":"He","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peiyan","family":"Bu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xionghui","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Zou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aimin","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,6,27]]},"reference":[{"issue":"11","key":"3186_CR1","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1038\/s41581-021-00462-y","volume":"17","author":"M Oshima","year":"2021","unstructured":"Oshima M, Shimizu M, Yamanouchi M, Toyama T, Hara A, Furuichi K, et al. Trajectories of kidney function in diabetes: a clinicopathological update. Nat Rev Nephrol. 2021;17(11):740\u201350.","journal-title":"Nat Rev Nephrol"},{"issue":"6","key":"3186_CR2","doi-asserted-by":"publisher","first-page":"884","DOI":"10.1053\/j.ajkd.2017.10.026","volume":"71","author":"K Umanath","year":"2018","unstructured":"Umanath K, Lewis JB. Update on diabetic nephropathy: core curriculum 2018. Am J Kidney Dis. 2018;71(6):884\u201395.","journal-title":"Am J Kidney Dis"},{"issue":"1","key":"3186_CR3","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1016\/j.dsx.2018.09.013","volume":"13","author":"A Esfandiari","year":"2019","unstructured":"Esfandiari A, Pourghassem Gargari B, Noshad H, Sarbakhsh P, Mobasseri M, Barzegari M, et al. The effects of vitamin D(3) supplementation on some metabolic and inflammatory markers in diabetic nephropathy patients with marginal status of vitamin D: a randomized double blind placebo controlled clinical trial. Diabetes Metab Syndr. 2019;13(1):278\u201383.","journal-title":"Diabetes Metab Syndr"},{"key":"3186_CR4","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.ejphar.2018.09.037","volume":"845","author":"X Hu","year":"2019","unstructured":"Hu X, Liu W, Yan Y, Liu H, Huang Q, Xiao Y, et al. Vitamin D protects against diabetic nephropathy: evidence-based effectiveness and mechanism. Eur J Pharmacol. 2019;845:91\u20138.","journal-title":"Eur J Pharmacol"},{"issue":"1","key":"3186_CR5","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.abb.2012.02.008","volume":"523","author":"LA Plum","year":"2012","unstructured":"Plum LA, Zella JB. Vitamin D compounds and diabetic nephropathy. Arch Biochem Biophys. 2012;523(1):87\u201394.","journal-title":"Arch Biochem Biophys"},{"issue":"1","key":"3186_CR6","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1053\/j.jrn.2020.02.003","volume":"31","author":"A Rastogi","year":"2021","unstructured":"Rastogi A, Bhatt N, Rossetti S, Beto J. Management of hyperphosphatemia in end-stage renal disease: a new paradigm. J Ren Nutr. 2021;31(1):21\u201334.","journal-title":"J Ren Nutr"},{"key":"3186_CR7","doi-asserted-by":"publisher","first-page":"4137268","DOI":"10.1155\/2020\/4137268","volume":"2020","author":"M Lei","year":"2020","unstructured":"Lei M, Liu Z, Guo J. The emerging role of vitamin D and vitamin D receptor in diabetic nephropathy. Biomed Res Int. 2020;2020:4137268.","journal-title":"Biomed Res Int"},{"issue":"1","key":"3186_CR8","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1186\/s12881-017-0458-8","volume":"18","author":"L Yang","year":"2017","unstructured":"Yang L, Wu L, Fan Y, Ma J. Vitamin D receptor gene polymorphisms in association with diabetic nephropathy: a systematic review and meta-analysis. BMC Med Genet. 2017;18(1):95.","journal-title":"BMC Med Genet"},{"issue":"3","key":"3186_CR9","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1016\/j.ajhg.2020.01.017","volume":"106","author":"D Manousaki","year":"2020","unstructured":"Manousaki D, Mitchell R, Dudding T, Haworth S, Harroud A, Forgetta V, et al. Genome-wide association study for vitamin D levels reveals 69 independent loci. Am J Hum Genet. 2020;106(3):327\u201337.","journal-title":"Am J Hum Genet"},{"issue":"11","key":"3186_CR10","doi-asserted-by":"publisher","first-page":"1870","DOI":"10.2215\/CJN.00910113","volume":"8","author":"G Fernandez-Juarez","year":"2013","unstructured":"Fernandez-Juarez G, Luno J, Barrio V, de Vinuesa SG, Praga M, Goicoechea M, et al. 25 (OH) vitamin D levels and renal disease progression in patients with type 2 diabetic nephropathy and blockade of the renin-angiotensin system. Clin J Am Soc Nephrol. 2013;8(11):1870\u20136.","journal-title":"Clin J Am Soc Nephrol"},{"issue":"1","key":"3186_CR11","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/j.ecl.2013.09.010","volume":"43","author":"J Mitri","year":"2014","unstructured":"Mitri J, Pittas AG. Vitamin D and diabetes. Endocrinol Metab Clin North Am. 2014;43(1):205\u201332.","journal-title":"Endocrinol Metab Clin North Am"},{"issue":"3","key":"3186_CR12","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.amjms.2018.12.005","volume":"357","author":"S Gupta","year":"2019","unstructured":"Gupta S, Goyal P, Feinn RS, Mattana J. Role of vitamin D and its analogues in diabetic nephropathy: a meta-analysis. Am J Med Sci. 2019;357(3):223\u20139.","journal-title":"Am J Med Sci"},{"issue":"1","key":"3186_CR13","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1159\/000498838","volume":"44","author":"Y Wang","year":"2019","unstructured":"Wang Y, Yang S, Zhou Q, Zhang H, Yi B. Effects of vitamin D supplementation on renal function, inflammation and glycemic control in patients with diabetic nephropathy: a systematic review and meta-analysis. Kidney Blood Press Res. 2019;44(1):72\u201387.","journal-title":"Kidney Blood Press Res"},{"issue":"2","key":"3186_CR14","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1080\/13685538.2018.1479385","volume":"22","author":"S Ucak","year":"2019","unstructured":"Ucak S, Sevim E, Ersoy D, Sivritepe R, Basat O, Atay S. Evaluation of the relationship between microalbuminuria and 25-(OH) vitamin D levels in patients with type 2 diabetes mellitus. Aging Male. 2019;22(2):116\u201320.","journal-title":"Aging Male"},{"issue":"11","key":"3186_CR15","doi-asserted-by":"publisher","first-page":"3253","DOI":"10.1681\/ASN.2016010098","volume":"27","author":"P Sekula","year":"2016","unstructured":"Sekula P, Del Greco MF, Pattaro C, K\u00f6ttgen A. Mendelian randomization as an approach to assess causality using observational data. J Am Soc Nephrol. 2016;27(11):3253\u201365.","journal-title":"J Am Soc Nephrol"},{"issue":"R1","key":"3186_CR16","doi-asserted-by":"publisher","first-page":"R89","DOI":"10.1093\/hmg\/ddu328","volume":"23","author":"G Davey Smith","year":"2014","unstructured":"Davey Smith G, Hemani G. Mendelian randomization: genetic anchors for causal inference in epidemiological studies. Hum Mol Genet. 2014;23(R1):R89-98.","journal-title":"Hum Mol Genet"},{"issue":"8","key":"3186_CR17","doi-asserted-by":"publisher","first-page":"e1001866","DOI":"10.1371\/journal.pmed.1001866","volume":"12","author":"LE Mokry","year":"2015","unstructured":"Mokry LE, Ross S, Ahmad OS, Forgetta V, Smith GD, Goltzman D, et al. Vitamin D and risk of multiple sclerosis: a Mendelian randomization study. PLoS Med. 2015;12(8):e1001866.","journal-title":"PLoS Med"},{"issue":"12","key":"3186_CR18","doi-asserted-by":"publisher","first-page":"2139","DOI":"10.1093\/ndt\/gfy074","volume":"33","author":"A Teumer","year":"2018","unstructured":"Teumer A, Gambaro G, Corre T, Bochud M, Vollenweider P, Guessous I, et al. Negative effect of vitamin D on kidney function: a Mendelian randomization study. Nephrol Dial Transplant. 2018;33(12):2139\u201345.","journal-title":"Nephrol Dial Transplant"},{"issue":"5","key":"3186_CR19","doi-asserted-by":"publisher","first-page":"1416","DOI":"10.1093\/ije\/dyy284","volume":"48","author":"X Jiang","year":"2019","unstructured":"Jiang X, Dimou NL, Al-Dabhani K, Lewis SJ, Martin RM, Haycock PC, et al. Circulating vitamin D concentrations and risk of breast and prostate cancer: a Mendelian randomization study. Int J Epidemiol. 2019;48(5):1416\u201324.","journal-title":"Int J Epidemiol"},{"issue":"6","key":"3186_CR20","doi-asserted-by":"publisher","first-page":"1130","DOI":"10.2337\/dc14-2330","volume":"38","author":"NM Panduru","year":"2015","unstructured":"Panduru NM, Sandholm N, Forsblom C, Saraheimo M, Dahlstrom EH, Thorn LM, et al. Kidney injury molecule-1 and the loss of kidney function in diabetic nephropathy: a likely causal link in patients with type 1 diabetes. Diabetes Care. 2015;38(6):1130\u20137.","journal-title":"Diabetes Care"},{"issue":"12","key":"3186_CR21","doi-asserted-by":"publisher","first-page":"4238","DOI":"10.2337\/db15-0254","volume":"64","author":"JN Todd","year":"2015","unstructured":"Todd JN, Dahlstrom EH, Salem RM, Sandholm N, Forsblom C, FinnDiane Study G, et al. Genetic evidence for a causal role of obesity in diabetic kidney disease. Diabetes. 2015;64(12):4238\u201346.","journal-title":"Diabetes."},{"issue":"3","key":"3186_CR22","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1093\/ije\/dyr036","volume":"40","author":"S Burgess","year":"2011","unstructured":"Burgess S, Thompson SG, Collaboration CCG. Avoiding bias from weak instruments in Mendelian randomization studies. Int J Epidemiol. 2011;40(3):755\u201364.","journal-title":"Int J Epidemiol"},{"issue":"1","key":"3186_CR23","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1038\/s41467-017-02662-2","volume":"9","author":"X Jiang","year":"2018","unstructured":"Jiang X, O\u2019Reilly PF, Aschard H, Hsu YH, Richards JB, Dupuis J, et al. Genome-wide association study in 79,366 European-ancestry individuals informs the genetic architecture of 25-hydroxyvitamin D levels. Nat Commun. 2018;9(1):260.","journal-title":"Nat Commun"},{"issue":"11","key":"3186_CR24","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1038\/ng.686","volume":"42","author":"EK Speliotes","year":"2010","unstructured":"Speliotes EK, Willer CJ, Berndt SI, Monda KL, Thorleifsson G, Jackson AU, et al. Association analyses of 249,796 individuals reveal 18 new loci associated with body mass index. Nat Genet. 2010;42(11):937\u201348.","journal-title":"Nat Genet"},{"key":"3186_CR25","doi-asserted-by":"publisher","first-page":"10023","DOI":"10.1038\/ncomms10023","volume":"7","author":"C Pattaro","year":"2016","unstructured":"Pattaro C, Teumer A, Gorski M, Chu AY, Li M, Mijatovic V, et al. Genetic associations at 53 loci highlight cell types and biological pathways relevant for kidney function. Nat Commun. 2016;7:10023.","journal-title":"Nat Commun"},{"issue":"3","key":"3186_CR26","doi-asserted-by":"publisher","first-page":"803","DOI":"10.2337\/db15-1313","volume":"65","author":"A Teumer","year":"2016","unstructured":"Teumer A, Tin A, Sorice R, Gorski M, Yeo NC, Chu AY, et al. Genome-wide association studies identify genetic Loci Associated With Albuminuria in Diabetes. Diabetes. 2016;65(3):803\u201317.","journal-title":"Diabetes"},{"issue":"7","key":"3186_CR27","doi-asserted-by":"publisher","first-page":"1414","DOI":"10.2337\/db17-0914","volume":"67","author":"NR van Zuydam","year":"2018","unstructured":"van Zuydam NR, Ahlqvist E, Sandholm N, Deshmukh H, Rayner NW, Abdalla M, et al. A Genome-wide association study of diabetic kidney disease in subjects with type 2 diabetes. Diabetes. 2018;67(7):1414\u201327.","journal-title":"Diabetes"},{"issue":"6460","key":"3186_CR28","doi-asserted-by":"publisher","first-page":"eaav7188","DOI":"10.1126\/science.aav7188","volume":"365","author":"International Multiple Sclerosis Genetics C","year":"2019","unstructured":"International Multiple Sclerosis Genetics C. Multiple sclerosis genomic map implicates peripheral immune cells and microglia in susceptibility. Science. 2019;365(6460):eaav7188.","journal-title":"Science"},{"issue":"5","key":"3186_CR29","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1007\/s10654-017-0255-x","volume":"32","author":"S Burgess","year":"2017","unstructured":"Burgess S, Thompson SG. Interpreting findings from Mendelian randomization using the MR-Egger method. Eur J Epidemiol. 2017;32(5):377\u201389.","journal-title":"Eur J Epidemiol"},{"issue":"5","key":"3186_CR30","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1038\/s41588-018-0099-7","volume":"50","author":"M Verbanck","year":"2018","unstructured":"Verbanck M, Chen CY, Neale B, Do R. Detection of widespread horizontal pleiotropy in causal relationships inferred from Mendelian randomization between complex traits and diseases. Nat Genet. 2018;50(5):693\u20138.","journal-title":"Nat Genet"},{"issue":"11","key":"3186_CR31","doi-asserted-by":"publisher","first-page":"e1007081","DOI":"10.1371\/journal.pgen.1007081","volume":"13","author":"G Hemani","year":"2017","unstructured":"Hemani G, Tilling K, Davey SG. Orienting the causal relationship between imprecisely measured traits using GWAS summary data. PLoS Genet. 2017;13(11):e1007081.","journal-title":"PLoS Genet"},{"issue":"5","key":"3186_CR32","doi-asserted-by":"publisher","first-page":"1497","DOI":"10.1093\/ije\/dyt179","volume":"42","author":"MJ Brion","year":"2013","unstructured":"Brion MJ, Shakhbazov K, Visscher PM. Calculating statistical power in Mendelian randomization studies. Int J Epidemiol. 2013;42(5):1497\u2013501.","journal-title":"Int J Epidemiol"},{"issue":"3","key":"3186_CR33","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1177\/0962280210394459","volume":"21","author":"TM Palmer","year":"2012","unstructured":"Palmer TM, Lawlor DA, Harbord RM, Sheehan NA, Tobias JH, Timpson NJ, et al. Using multiple genetic variants as instrumental variables for modifiable risk factors. Stat Methods Med Res. 2012;21(3):223\u201342.","journal-title":"Stat Methods Med Res"},{"issue":"7","key":"3186_CR34","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1038\/ng.610","volume":"42","author":"JH Park","year":"2010","unstructured":"Park JH, Wacholder S, Gail MH, Peters U, Jacobs KB, Chanock SJ, et al. Estimation of effect size distribution from genome-wide association studies and implications for future discoveries. Nat Genet. 2010;42(7):570\u20135.","journal-title":"Nat Genet"},{"key":"3186_CR35","doi-asserted-by":"publisher","first-page":"4408","DOI":"10.7554\/eLife.34408","volume":"7","author":"G Hemani","year":"2018","unstructured":"Hemani G, Zheng J, Elsworth B, Wade KH, Haberland V, Baird D, et al. The MR-Base platform supports systematic causal inference across the human phenome. Elife. 2018;7:4408.","journal-title":"Elife"},{"issue":"22","key":"3186_CR36","doi-asserted-by":"publisher","first-page":"4851","DOI":"10.1093\/bioinformatics\/btz469","volume":"35","author":"MA Kamat","year":"2019","unstructured":"Kamat MA, Blackshaw JA, Young R, Surendran P, Burgess S, Danesh J, et al. PhenoScanner V2: an expanded tool for searching human genotype-phenotype associations. Bioinformatics. 2019;35(22):4851\u20133.","journal-title":"Bioinformatics"},{"issue":"11","key":"3186_CR37","doi-asserted-by":"publisher","first-page":"1769","DOI":"10.1016\/j.drudis.2014.06.008","volume":"19","author":"AC Sintov","year":"2014","unstructured":"Sintov AC, Yarmolinsky L, Dahan A, Ben-Shabat S. Pharmacological effects of vitamin D and its analogs: recent developments. Drug Discov Today. 2014;19(11):1769\u201374.","journal-title":"Drug Discov Today"}],"container-title":["BMC Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-023-03186-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12882-023-03186-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-023-03186-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,28]],"date-time":"2023-06-28T03:03:29Z","timestamp":1687921409000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcnephrol.biomedcentral.com\/articles\/10.1186\/s12882-023-03186-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,27]]},"references-count":37,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["3186"],"URL":"https:\/\/doi.org\/10.1186\/s12882-023-03186-2","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-1863340\/v1","asserted-by":"object"}]},"ISSN":["1471-2369"],"issn-type":[{"value":"1471-2369","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,6,27]]},"assertion":[{"value":"16 July 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 April 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 June 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This MR study is performed using GWAS summary statistics, and ethical approval was obtained by each GWAS.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"192"}}